Hydroxyzine hydrochloride

Product NDC
70518-1692
Requested package NDC
70518-1692-2
11-digit product format
705181692
Labeler code
70518
Product ID
70518-1692_496167aa-84ed-70f9-e063-6394a90ac9fb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Hydroxyzine hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA204279
Marketing category
ANDA
Marketing start
2018-11-26
Substance
HYDROXYZINE DIHYDROCHLORIDE
Active strength
25 mg/1
Pharmacologic classes
Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A204279-001HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-20
A204279-002HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE25MGTABLET / ORALAB2014-08-20
A204279-003HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE50MGTABLET / ORALAB2014-08-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A204279-001AB
A204279-002AB
A204279-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A204279-001HYDROXYZINE HYDROCHLORIDE10MGTABLET / ORALAB2014-08-20a50c72e98297…
2026-08-01 22:54:322026-06A204279-002HYDROXYZINE HYDROCHLORIDE25MGTABLET / ORALAB2014-08-20a50c72e98297…
2026-08-01 22:54:322026-06A204279-003HYDROXYZINE HYDROCHLORIDE50MGTABLET / ORALAB2014-08-20a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A204279-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A204279-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A204279-003AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 2 · 37 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEMajor Pharmaceuticals7f76580c-96a0-4b56-8986-ff5488bb98692026-07-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEREMEDYREPACK INC.bb4a7d22-2f42-4e9f-bf98-cee43ed14d502026-07-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEPreferred Pharmaceuticals Incc8b441bf-a03e-47b3-8f06-c347f5ca4b702026-07-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEREMEDYREPACK INC.b6189074-e199-4f58-a78d-c04f131c13d92026-07-10Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
ndc (package): 70518-1692-2
ndc (product): 70518-1692
ndc11 (package): 70518169202
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEProficient Rx LP83e8d60d-36fd-4223-b50c-e6615045352a2026-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEUnit Dose Solutions, Inc.5506e802-0efc-a845-e063-6394a90aad0e2026-06-24Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEPreferred Pharmaceuticals Incl63fdf791-1a58-45ba-8ef2-15b80bb24f232026-05-11Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDECoupler LLC508848a5-017c-dd3e-e063-6294a90a456b2026-04-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDENuCare Pharmaceuticals, Inc.4cd84205-6a33-db48-e063-6394a90a91822026-04-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEREMEDYREPACK INC.71eea118-395c-4559-aed5-900b635674b82026-02-12Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEA-S Medication Solutions1350964e-663e-4a50-8c4c-cda371a694a02026-02-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEREMEDYREPACK INC.4c2c4d8e-c3d1-48c7-8f99-ffa1596674652026-01-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDENorthwind Health Company, LLCf2b3d10f-2599-5b71-e053-2a95a90a54bb2026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDENorthwind Health Company, LLCc134195e-a048-530a-e053-2a95a90ad9f82025-12-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDENorthwind Health Company, LLCc13455a3-3078-4fe1-e053-2a95a90adf8e2025-12-26Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine HydrochlorideHYDROXYZINE HYDROCHLORIDEChartwell RX, LLC6533bb4f-efbc-4fca-b625-daa1b39787402025-12-10Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDEDirect Rxd956063a-ef48-faca-e053-2995a90a02912025-10-06Exact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEPD-Rx Pharmaceuticals, Inc.ca015a35-1f94-4f92-9143-3f149982d3162025-07-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEGolden State Medical Supply, Inc.2fc9b08a-e675-dbc5-e063-6294a90ad0542025-07-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279
Hydroxyzine hydrochlorideHYDROXYZINE HYDROCHLORIDEBryant Ranch Prepacke4c60e14-28c7-46e2-9fdc-b1a1ce54f3c22025-06-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 204279
application number: ANDA204279

Additional Listing Data#

Finished product
Yes
Brand name base
Hydroxyzine hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYDROXYZINE DIHYDROCHLORIDE25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
76755771U3Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
995258Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
b6189074-e199-4f58-a78d-c04f131c13d9Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
57311cfb-679a-da1a-b70c-8757f7fc431aProduct name420250516
aa1826f4-97c1-4705-bdf0-3bc7d234e618Product name220190618
75cb12ee-8eb2-4f1a-a332-5743a5d0da41Product name120151110
3ca5f78b-43dc-30fe-8014-55b922af52b3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-1692-0Hydroxyzine hydrochloride30 in 1 BLISTER PACKTABLET3013
70518-1692-1Hydroxyzine hydrochloride15 in 1 BOTTLE, PLASTICTABLET1513
70518-1692-2Hydroxyzine hydrochloride30 in 1 BOTTLE, PLASTICTABLET3013

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-1692HYDROXYZINE HYDROCHLORIDE TABLET [REMEDYREPACK INC.]11Current NDC, Legacy NDC, 3 package rows20250227_b6189074-e199-4f58-a78d-c04f131c13d9.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
995258hydrOXYzine HCl 25 MG Oral TabletPSNb6189074-e199-4f58-a78d-c04f131c13d913
995258hydroxyzine hydrochloride 25 MG Oral TabletSCDb6189074-e199-4f58-a78d-c04f131c13d913

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70518-1692-27051816920230 TABLET in 1 BOTTLE, PLASTIC (70518-1692-2) 30 tablet2024-09-13NoNoCurrent